Answers are grounded in this paper and cite their sources.
Background: Early recovery after major hepatectomy may depend not only on remnant liver volume, but also on whether the injury-adjacent remnant-liver boundary can withstand the narrow postoperative convergence of mechanical disruption, inflammatory amplification, and transient metabolic insufficiency that may otherwise divert the remnant liver away from productive regeneration.Methods: We engineered an organoid tissue patch (OTP) by integrating matrix-free expanded human bile-derived liver organoids with a reticulated microfibrous scaffold for localized deployment on the remnant liver surface.OTP was evaluated in a murine 70% partial hepatectomy model using survival, serum biochemical, histological, and molecular analyses, together with pharmacologic PPARα inhibition.Results: OTP treatment was associated with improved survival and biochemical recovery, together with attenuated tissue injury in the predefined patch-placement region.At Day 3, OTP-treated tissue showed reduced NF-κB-linked inflammatory activity, lower inflammatory mediator expression, and an increased CD206-associated macrophage signal.Metabolism-and proliferationrelated programs were concurrently enriched, accompanied by increased PPARα immunoreactivity, YAP-positive nuclei, and hepatocyte proliferative entry.Systemic PPARα inhibition partially attenuated these effects, supporting a functional contribution of PPARα-responsive signaling.Conclusions: These findings support localized OTP deployment as a strategy to provide temporary bioactive support to the vulnerable remnant-liver boundary during endogenous recovery, without evidence of bulk donor tissue replacement.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: